DailyDoctor Archive Specialties Get app
All cardiology briefings

The edition · Cardiology

Calcium scoring earns its place at borderline PREVENT risk

Adding a calcium score to PREVENT barely moves overall prediction but splits borderline-risk patients sharply, while pooled tenecteplase data put numbers on age, dose and blood pressure as bleeding risks.

The edition in brief

In 6,098 MESA participants followed for ten years, adding a coronary artery calcium score to the PREVENT atherosclerotic risk equations raised the C statistic only from 0.73 by 0.02 overall. But within the borderline band, 3% to under 5%, event rates ran from 1.9% with a score of zero to 14.3% with a score of 300 or more — the case for selective scanning that the 2026 dyslipidaemia guideline makes. A pooled analysis of 15,954 STEMI patients from six tenecteplase trials found that intracranial haemorrhage risk rose about 2% per mmHg of systolic pressure above 110, sharply above 160, and climbed more steeply with age at the full 50 mg dose; female sex and low body weight added risk. A network meta-analysis of five trials found oral PCSK9 inhibitors lowered LDL cholesterol by up to about 60% against placebo, with no short-term safety signal and low-certainty comparisons between agents. The CHIPS trial found platelets cold-stored for up to 21 days were non-inferior to room-temperature platelets for bleeding in cardiac surgery, with more re-explorations. The 2026 US perioperative guideline for non-cardiac surgery replaces the 2014 version. The pearl covers how to talk about a zero calcium score.

In this edition
01
Clinical update

Who bleeds into the brain after tenecteplase

Before fibrinolysis, bring systolic pressure down and consider a reduced tenecteplase dose in older patients.

2 min · European heart journalRead →
Primary outcome
Intracranial haemorrhage (169 events)
Effect
aOR 1.02 per mmHg SBP above 110; female sex aOR 1.49 (1.06–2.11); per 5 kg lower weight aOR 1.16
02Research

Oral PCSK9 inhibitors: how far LDL falls

Oral PCSK9 inhibitors lower LDL about as much as injectables in short trials; outcome data and approvals will decide their place.

1 min · EndocrineRead →
03Research

Cold-stored platelets in cardiac surgery

Cold-stored platelets are a credible way to extend platelet supply for cardiac surgery, with re-exploration to watch.

1 min · JAMARead →
04Clinical update

The 2026 US perioperative guideline replaces 2014

Update pre-operative assessment pathways to the 2026 guideline, which replaces the 2014 version.

1 min · Journal of the American College of CardiologyRead →
05Pearl

Talking through a zero calcium score

Use a zero score to support deferring a statin only in borderline or intermediate-risk patients without high-risk features.

1 minRead →
06
Practice changer

Where a calcium score changes the PREVENT decision

Order a calcium score where PREVENT puts a patient between 3% and 10%; outside that band it rarely changes the decision.

2 min · JAMARead →
Primary outcome
Fatal and non-fatal atherosclerotic events (366 events)
Effect
ΔC statistic 0.02 (0.01–0.03); NRI 0.095; borderline-risk event rate 1.9% (CAC 0) to 14.3% (CAC ≥300)

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for cardiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free